Caldera Medical has expanded its hysteroscopy portfolio with the acquisition of UVision 360, the creator of the LUMINELLE hysteroscopy and cystoscopy systems.
This move enhances Caldera Medical’s minimally invasive portfolio, offering advanced solutions for the diagnosis and treatment of gynaecological conditions like fibroids, polyps and intrauterine pathology.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The LUMINELLE system offers high-resolution optics and user-friendly design, providing a cost-effective option for both therapeutic and diagnostic hysteroscopy.
It is compatible with current surgical workflows as it serves as a desirable choice for gynaecologic surgeons aiming for minimally invasive solutions that improve procedural accuracy and patient recovery time.
Caldera Medical CEO Bryon Merade said: “We are excited to integrate LUMINELLE’s technology into Caldera Medical’s growing portfolio.
“This acquisition strengthens our commitment to offering gynecologic surgeons state-of-the-art tools that streamline hysteroscopic procedures while enhancing patient safety and clinical outcomes.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe integration of the company’s Benesta product line with LUMINELLE provides enhanced procedural capabilities for gynaecologic surgeons.
This combination is set to improve clinical outcomes for a variety of intrauterine treatments such as biopsies, polypectomies and fibroid resections, in office settings as well as surgical environments.
LUMINELLE CEO and co-founder Allison London Brown said: “The LUMINELLE team has worked diligently to finally provide an accurate and easy diagnosis to a growing deadly disease, uterine cancer.
“We are excited that Caldera Medical shares our vision and will accomplish this mission.”
Caldera Medical offers a portfolio that can be used for treatments such as pelvic organ prolapse, stress urinary incontinence and gynaecologic conditions.
The company has partnered with its surgeon partners to operate a humanitarian programme in women’s health.
